DANA D. HU-LOWE

Person

ENCINITAS, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Human monoclonal antibodies to activin receptor-like kinase-1
- Patent number 9,221,915
- Issue date Dec 29, 2015
- Pfizer Inc.
- Shelley Sims Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha5-beta1 antibodies and their uses
- Patent number 8,399,647
- Issue date Mar 19, 2013
- Pfizer Inc.
- Steven L. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human monoclonal antibodies to activin receptor-like kinase-1
- Patent number 8,080,646
- Issue date Dec 20, 2011
- Amgen Fremont, Inc.
- Michael Aidan North
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha 5-beta 1 antibodies and their uses
- Patent number 8,039,596
- Issue date Oct 18, 2011
- Bristol-Myers Squibb Company
- Steven Lee Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human monoclonal antibodies to activin receptor-like kinase-1
- Patent number 7,537,762
- Issue date May 26, 2009
- Amgen Fremont, Inc.
- Michael Aidan North
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indazole compounds and pharmaceutical compositions for inhibiting p...
- Patent number 7,141,581
- Issue date Nov 28, 2006
- Agouron Pharmaceuticals, Inc.
- Steven Bender
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ALPHA5-BETA1 ANTIBODIES AND THEIR USES
- Publication number 20140154268
- Publication date Jun 5, 2014
- PFIZER INC.
- STEVEN LEE BENDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN MONOCLONAL ANTIBODIES TO ACTIVIN RECEPTOR-LIKE KINASE-1
- Publication number 20120052074
- Publication date Mar 1, 2012
- Pfizer Inc.
- Shelley Sims Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALPHA5-BETA1 ANTIBODIES AND THEIR USES
- Publication number 20120009622
- Publication date Jan 12, 2012
- STEVEN L. BENDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALPHA 5 - BETA 1 ANTIBODIES AND THEIR USES
- Publication number 20100330078
- Publication date Dec 30, 2010
- STEVEN L. BENDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN MONOCLONAL ANTIBODIES TO ACTIVIN RECEPTOR-LIKE KINASE-1
- Publication number 20100197005
- Publication date Aug 5, 2010
- Amgen Fremont Inc.
- Shelley Sims Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human monoclonal antibodies to activin receptor-like kinase-1
- Publication number 20070065444
- Publication date Mar 22, 2007
- Amgen Fremont Inc.
- Michael Aidan North
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Indazole compounds and pharmaceutical compositions for inhibiting p...
- Publication number 20050038097
- Publication date Feb 17, 2005
- Steven Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Dosage forms and methods of treatment using VEGFR inhibitors
- Publication number 20040224988
- Publication date Nov 11, 2004
- Agouron Pharmaceuticals, Inc.
- James Freddo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

DANA D. HU-LOWE

Person

Patents Grantslast 30 patents

Human monoclonal antibodies to activin receptor-like kinase-1

Alpha5-beta1 antibodies and their uses

Human monoclonal antibodies to activin receptor-like kinase-1

Alpha 5-beta 1 antibodies and their uses

Human monoclonal antibodies to activin receptor-like kinase-1

Indazole compounds and pharmaceutical compositions for inhibiting p...

Patents Applicationslast 30 patents

ALPHA5-BETA1 ANTIBODIES AND THEIR USES

HUMAN MONOCLONAL ANTIBODIES TO ACTIVIN RECEPTOR-LIKE KINASE-1

ALPHA5-BETA1 ANTIBODIES AND THEIR USES

ALPHA 5 - BETA 1 ANTIBODIES AND THEIR USES

HUMAN MONOCLONAL ANTIBODIES TO ACTIVIN RECEPTOR-LIKE KINASE-1

Human monoclonal antibodies to activin receptor-like kinase-1

Indazole compounds and pharmaceutical compositions for inhibiting p...

Dosage forms and methods of treatment using VEGFR inhibitors